High Tech Campus 32
Eindhoven NL-5656
Netherlands
https://www.onwd.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 96
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. David L. Marver | CEO & Director | 961k | N/A | 1968 |
Dr. Gregoire Courtine Ph.D. | Chief Scientific Officer & Director | N/A | N/A | 1975 |
Mr. Khaled Bahi | Interim Chief Financial Officer | N/A | N/A | 1966 |
Mr. Robert W. Odell | Vice President of Operations | N/A | N/A | 1960 |
Mr. John Murphy | Chief Technology Officer | N/A | N/A | N/A |
Sarah Moore | Vice President of Global Marketing | N/A | N/A | N/A |
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.